Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 37, Issue 4 (Apr 1999)

Issues

Age Relationships and Sex Differences in Serum Levels of Pregnenolone and 17-Hydroxypregnenolone in Normal Subjects

Martin Hill / Dušan Lukáč / Oldrrich Lapčík / Jarmila Šulcová / Richard Hampl / Vladimír Pouzar / Luboslav Stárka
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1999.072

Abstract

17-Hydroxypregnenolone (3β, 17α-dihydroxypregn-5-en-20-one) and pregnenolone (3β-hydroxypregn-5-en-20-one) were determined by radioimmunoassay following HPLC separation in serum of healthy subjects of both sexes from 2 to 66 years old (29 girls, 85 women, 30 boys, 89 men). The effects of age and sex on the levels of both steroids were investigated and the upper limits of normal in age groups were determined.

The 17-hydroxypregnenolone levels as a function of age were characterized by a statistically significant maximum at the age of 18 and 20 years followed by a local minimum at the age of 39 and 37 years and by a statistically insignificant local maximum at the age of 55 and 49 years in men and women, respectively.

Pregnenolone age-dependence was similar and the statistically significant maximum was reached at the age of 17 and 16 years, the local minimum occurred at the age of 37 and 38 years and the second, statistically insignificant, local maximum at the age of 48 and 47 years in men and women, respectively.

Both 17-hydroxypregnenolone and pregnenolone in both sexes exhibited similarly shaped peaks with age. Both peaks of the polynomial fit in 17-hydroxypregnenolone were more pronounced in men than in women (13.0 and 9.20 nmol/l in the first peak; 7.72 and 4.78 in the second peak respectively). The situation with pregnenolone was the opposite. Both peaks of the polynomial fit in pregnenolone were lower in men than in women (2.29 and 3.21 nmol/l in the first peak; 0.92 and 1.78 in the second peak, respectively).

The higher serum levels of pregnenolone at puberty and during fertile age and their wider variance in comparison with men could, be explained by the different gonadal steroidogenesis depending on the menstrual cycle, where the pregnenolone serves as a substrate for progesterone formation.

The age dependencies of 17-hydroxypregnenolone and pregnenolone in women resembled that of unconjugated dehydroepiandrosterone. These results indicate that the increased metabolic activity in gonads in adolescence concerns not only dehydroepiandrosterone as the product of the 5-ene metabolic pathway but also its precursors.

About the article

Published Online: 2005-06-01

Published in Print: 1999-04-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1999.072.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Graeme Eisenhofer, Mirko Peitzsch, Denise Kaden, Katharina Langton, Christina Pamporaki, Jimmy Masjkur, George Tsatsaronis, Anastasios Mangelis, Tracy A. Williams, Martin Reincke, Jacques W.M. Lenders, and Stefan R. Bornstein
Clinica Chimica Acta, 2017, Volume 470, Page 115
[2]
Matthew D Krasowski, Denny Drees, Cory S Morris, Jon Maakestad, John L Blau, and Sean Ekins
BMC Clinical Pathology, 2014, Volume 14, Number 1
[3]
Emmanuelle Sarzi, Marie Seveno, Claire Angebault, Dan Milea, Cecilia Rönnbäck, Melanie Quilès, Mathias Adrian, Joanna Grenier, Angélique Caignard, Annie Lacroux, Christian Lavergne, Pascal Reynier, Michael Larsen, Christian P Hamel, Guy Lenaers, and Agnès Müller
Human Molecular Genetics, 2016, Page ddw117
[4]
Michael S. Ritsner, Hisham Bawakny, and Anatoly Kreinin
Psychiatry and Clinical Neurosciences, 2014, Volume 68, Number 6, Page 432
[5]
Jinpei Kumagai, Johannes Hofland, Sigrun Erkens-Schulze, Natasja F.J. Dits, Jacobie Steenbergen, Guido Jenster, Yukio Homma, Frank H. de Jong, and Wytske M. van Weerden
The Prostate, 2013, Page n/a
[6]
Robert Morfin
The Journal of Steroid Biochemistry and Molecular Biology, 2002, Volume 80, Number 3, Page 273
[7]
M Hill, A Pařı́zek, J Klak, R Hampl, J Šulcová, H Havlı́ková, O Lapčı́k, M Bičı́ková, T Fait, R Kancheva, D Cibula, V Pouzar, M Meloun, and L Stárka
The Journal of Steroid Biochemistry and Molecular Biology, 2002, Volume 82, Number 2-3, Page 241
[8]
M. Schumacher, S. Weill-Engerer, P. Liere, F. Robert, R.J.M. Franklin, L.M. Garcia-Segura, J.J. Lambert, W. Mayo, R.C. Melcangi, A. Parducz, U. Suter, C. Carelli, E.E. Baulieu, and Y. Akwa
Progress in Neurobiology, 2003, Volume 71, Number 1, Page 3
[9]
A.W. Meikle, M.M. Kushnir, A:L. Rockwood, E.G. Pattison, A.H. Terry, T. Sandrock, A.M. Bunker, A.R. Phanslkar, W.E. Owen, and W.L. Roberts
Journal of Pediatric Endocrinology and Metabolism, 2007, Volume 20, Number 12
[10]
Marie Bičíková, Daniela Řípová, Martin Hill, Roman Jirák, Helena Havlíková, Jaroslava Tallová, and Richard Hampl
Clinical Chemistry and Laboratory Medicine (CCLM), 2004, Volume 42, Number 5
[11]
Martin Hill, Helena Havlíková, Jan Klak, Marie Bičíková, Vladimír Pouzar, Richard Hampl, and Luboslav Stárka
Collection of Czechoslovak Chemical Communications, 2002, Volume 67, Number 1, Page 140

Comments (0)

Please log in or register to comment.
Log in